Registry of Lobbyists

Monthly Communication Report

370107-628614

Corporation: Moderna Biopharma Canada Corporation
Associated registration: 956349-370107-16
Communication date: 2024-12-05
Posted date: 2025-01-13

Designated Public Office Holders who participated in the communication: Greg Orencsak, Deputy Minister
Health Canada (HC)
 
List of Details
Subject matter Detail
Government Procurement, Health Health Canada and Public Services and Procurement Canada policies regarding the development, procurement, and distribution of Moderna’s COVID-19 vaccine to various segments of the population, including future distribution models
Economic Development, Health The government’s Pandemic Preparedness Strategy as it relates to the corporation’s future operations in Canada
 
Responsible Officer who filed this communication report: Stefan Raos
 
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication.

The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
 

Date Modified: